Índice

• • ·Editorial Board

    Página :CO2

    

• ADHD: burden of life, awareness and treatments

  • ·The burdened life of adults with ADHD: Impairment beyond comorbidity

    Página :309-313

    C.R. Garcia, C.H.D. Bau, K.L. Silva, S.M. Callegari-Jacques, C.A.I. Salgado, A.G. Fischer, M.M. Victor, N.O. Sousa, R.G. Karam, L.A. Rohde, P. Belmonte-de-Abreu, E.H. Grevet

    Resumen Resumen Esquema Esquema
  • ·Low self-awareness of ADHD in adults using a self-report screening questionnaire

    Página :314-320

    I. Manor, N. Vurembrandt, S. Rozen, D. Gevah, A. Weizman, G. Zalsman

    Resumen Resumen Esquema Esquema  
  • ·German validation of the Conners Adult ADHD Rating Scales (CAARS) II: Reliability, validity, diagnostic sensitivity and specificity

    Página :321-328

    H. Christiansen, B. Kis, O. Hirsch, S. Matthies, J. Hebebrand, J. Uekermann, M. Abdel-Hamid, M. Kraemer, J. Wiltfang, E. Graf, M. Colla, E. Sobanski, B. Alm, M. Rösler, C. Jacob, T. Jans, M. Huss, B.G. Schimmelmann, A. Philipsen

    Resumen Resumen Esquema Esquema  
  • ·Parent-reported attention-deficit hyperactivity disorder and subtypes of conduct disorder as risk factor of recidivism in detained male adolescents

    Página :329-334

    O. Colins, R. Vermeiren, P. Vahl, M. Markus, E. Broekaert, T. Doreleijers

    Resumen Resumen Esquema Esquema
  • ·The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: A double-blind placebo-controlled trial, followed by an open-label extension

    Página :335-342

    I. Manor, A. Magen, D. Keidar, S. Rosen, H. Tasker, T. Cohen, Y. Richter, D. Zaaroor-Regev, Y. Manor, A. Weizman

    Resumen Resumen Esquema Esquema  
  • ·Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: A systematic review

    Página :343-349

    H. Caisley, U. Müller

    Resumen Resumen Esquema Esquema  

• Schizophrenia, thought disorders and cognition

  • ·The stability of severe thought disorders and mature thinking

    Página :350-357

    S.M. Kaakinen, A. Säkkinen, K.-E. Wahlberg, H. Hakko, J. Holma, P. Tienari

    Resumen Resumen Esquema Esquema  
  • ·Mental state attribution in schizophrenia: What distinguishes patients with “poor” from patients with “fair” mentalising skills?

    Página :358-364

    M. Brüne, D. Schaub

    Resumen Resumen Esquema Esquema
  • ·Neurocognitive functions of heavy cannabis using schizophrenia patients

    Página :365-368

    S. Lev-Ran, A. Segev, Y. Braw, Y. Levkovitz

    Resumen Resumen Esquema Esquema

• Genetic risk factors in different psychiatric disorders

  • ·Association of the intronic rs2072621 polymorphism of the X-linked GPR50 gene with affective disorder with seasonal pattern

    Página :369-371

    M. Delavest, C. Even, N. Benjemaa, M.-F. Poirier, R. Jockers, M.-O. Krebs

    Resumen Resumen Esquema Esquema
  • ·HapMap tag-SNP analysis confirms a role for COMT in schizophrenia risk and reveals a novel association

    Página :372-376

    J. Voisey, C.D. Swagell, I.P. Hughes, B.R. Lawford, R.M. Young, C.P. Morris

    Resumen Resumen Esquema Esquema
  • ·Anterior cingulate morphology in people at genetic high-risk of schizophrenia

    Página :377-385

    S.M. Meredith, N.C.A. Whyler, A.C. Stanfield, G. Chakirova, T.W.J. Moorhead, D.E. Job, S. Giles, A.M. McIntosh, E.C. Johnstone, S.M. Lawrie

    Resumen Resumen Esquema Esquema  
  • ·Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder

    Página :386-390

    M.A. Fullana, P. Alonso, M. Gratacòs, N. Jaurrieta, S. Jiménez-Murcia, C. Segalàs, E. Real, X. Estivill, J.M. Menchón

    Resumen Resumen Esquema Esquema